How to Buy Lantheus Holdings Stock
Lantheus Holdings Inc
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide.
Lantheus Holdings stock last closed at $108.56, up 0.39% from the previous day, and has increased 71.72% in one year. It has overperformed other stocks in the Drug Manufacturers - Specialty & Generic industry by 1.07 percentage points. Lantheus Holdings stock is currently +116.25% from its 52-week low of $50.20, and -14.45% from its 52-week high of $126.89.
At the moment, there are 69.43M LNTH shares outstanding. The market capitalization of LNTH is $7.54B. In the past 24 hours, 887,641 LNTH shares were traded.
How to Buy Lantheus Holdings Stock
Wondering how to invest in Lantheus Holdings stock? Here's how.
- Choose where to buy Lantheus Holdings stock: You need to pick a stock brokerage, but don't worry - we've analyzed dozens of online stock brokerages and apps to help you decide where to buy Lantheus Holdings stock.
- Sign up for your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
- Deposit money your brokerage account: Choose your method of payment and add your info.
- Research Lantheus Holdings stock: The Lantheus Holdings ticker symbol is LNTH. Is Lantheus Holdings stock a good investment? Should you buy shares of LNTH? How do LNTH's underlying business fundamentals look? Do top analysts think Lantheus Holdings is a good buy? Why has LNTH's stock price moved recently? (Hint: Our stock market research website can help you decide if LNTH is a good stock to buy).
- Make your LNTH purchase: Decide if you will purchase LNTH shares at the current market price or use a limit order to purchase LNTH stock at a particular price.
- Track your investment in LNTH: Create a watchlist to important updates regarding your investment in Lantheus Holdings stock.
Step 1: Choose where to buy Lantheus Holdings stock
You will need a brokerage account to access the NASDAQ market and buy LNTH stock.
Our preferred brokerage: eToro
Based on our analysis, eToro is the best brokerage. Here's why:
- Invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
- Access to world financial markets: From Technology to Energy, New York to Shanghai — you can fill your portfolio with stocks from the globe's top exchanges.
- Social investing: eToro boasts a community with more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your stock purchase by creating an account with eToro today.
Open eToro AccountStep 2: Sign up for your brokerage account
Now that you've selected the best brokerage, it's time to fill out some personal details so you can invest in LNTH today.
How to Start a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal details to create your new trading account.
- Submit your data by pressing the "Create Account" button. Get started with eToro today
Step 3: Deposit money your brokerage account
Now that you have filled out your info on the best stock broker app, you can securely and quickly fund your account:
Check out this video walkthrough to see the process of depositing money into your brokerage account.
Step 4: Research Lantheus Holdings stock
Once you have identified the best place to buy Lantheus Holdings stock, it's important to analyze their stock prior to investing, so you actually wrap your head around the risk as well as the upside.
Lantheus Holdings stock at a glance
LNTH Fundamentals
WallStreetZen was created to help part-time investors perform more accurate fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on LNTH's stock page.
Is LNTH stock overvalued?
You can use a variety of different financial metrics, analyses, models, and charts to gauge LNTH's true value.
Using relative valuations ratios:
- LNTH could be undervalued based on its P/E ratio of 17.37x, relative to Drug Manufacturers - Specialty & Generic industry P/E ratio of 20.52x
- LNTH could be overvalued based on its P/B ratio of 7.34x, relative to Drug Manufacturers - Specialty & Generic industry P/B ratio of 2.33x
- LNTH may be overvalued based on its PEG ratio of 3.13x
You can access more valuation analysis on LNTH's stock here.
LNTH Financial Health Overview
Positive Financial Indicators:
- LNTH profit margin has gone up from 3% to 29.8% in the past year.
- There are more short-term assets than short-term liabilities on the LNTH balance sheet.
- There are more short-term assets than long-term liabilities on the LNTH balance sheet.
- Total LNTH debt is lower than 5 years ago, relative to shareholder equity.
- LNTH's operating cash flow of $440.98M allows it to safely service it's debt of $564.06M.
- LNTH earnings of $573.82M is not sufficient to cover its interest payments.
Negative Financial Indicators:
- LNTH has a relatively high debt to equity ratio of 0.89.
Is Lantheus Holdings stock a Buy, Hold, or Sell, according to analysts?
Out of 5 sell side analysts who give ratings on LNTH, the consensus analyst rating on LNTH is a Strong Buy
Please keep in mind that analyst forecasts are not stock recommendations, nor are they investment advice.
Latest LNTH Analyst Upgrades/Downgrades
Anthony Petrone, a top 8% analyst from Mizuho maintains LNTH with a strong buy rating and raises their LNTH price target from $90.00 to $100.00, on May 3, 2024.
Mizuho's Anthony Petrone raised their price target on Lantheus Holdings (NASDAQ: LNTH) by 11.1% from $90 to $100 on 2024/05/03. The analyst maintained their Strong Buy rating on the stock.
Lantheus Holdings' quarterly results beat expectations, Petrone said to summarize the company's Q1 2024 print, released on 2024/05/02.
PYLARIFY has a lot of great things to contribute to 2H 2024's momentum, the analyst added.
Footnotes
PYLARIFY® is an injectable fluorinated small molecule PSMA-targeted PET imaging agent that enables visualization of lymph nodes, bone, and soft tissue metastases to determine the presence or absence of recurrent and/or metastatic prostate cancer.
PSMA (Prostate-Specific Membrane Antigen) is a protein typically found in prostate cancer cells.
PET (Positron Emission Tomography) scan is a powerful imaging technique that provides valuable insights into the metabolic or biochemical function of tissues and organs within the body.
Earnings Report
For Q1 2024, Lantheus Holdings reported:
- EPS of $1.69, which beat the Zacks Consensus Estimate of $1.55 and, by 15.2%, Q1 2023’s $1.47.
- Revenue of $369.98M, which beat the Zacks Consensus Estimate by 5.87% and, by 23%, Q1 2023’s $300.78M.
Management guided:
For Q2 2024:
- EPS of $1.81 to $1.86
- Revenue of $380M to $390M.
For FY 2024:
- EPS of $7.00 to $7.20
- Revenue of $1.50B to $1.52B.
CEO Brian Markison commented: “Strong Q1 performance underscores the company’s commercial excellence and innovation, as we once again delivered outstanding results while continuing to make strategic investments that advance and expand our pipeline.
“Our market-leading commercial portfolio, fully integrated capabilities, and strong financial position, including our significant cash flow and access to capital, provide a foundation for continued growth.
“Utilizing our radiopharmaceutical expertise and financial resources, we will invest in our current business to maximize value and evaluate business development and M&A opportunities in both diagnostics and therapeutics to continue enhancing our pipeline and capabilities."
You can dive deeper into what analysts are projecting on the Lantheus Holdings stock forecast page.
LNTH Trading Indicators
LNTH Performance Metrics
Last year, LNTH earnings were $428.48M. Over the last 5 year, LNTH's earnings have grown by 43.98% per year. This was faster than the Drug Manufacturers - Specialty & Generic industry average of 11.38%.
Last year, LNTH revenue was $1.44B. During the last 5 year, LNTH's revenue has gone up by 32.86% per year. This was faster than the Drug Manufacturers - Specialty & Generic industry average of 19.82%.
Dive into LNTH's earnings and revenue performance here.
What are LNTH insiders up to?
In the past 12 months, insiders at LNTH have sold more shares than they have bought.
Robert J. Marshall Jr., CFO and Treasurer of LNTH, was the latest LNTH insider to sell. They sold $82,380.66 worth of LNTH shares on Aug 29, 2024.
Research more about who owns LNTH shares here.
Does LNTH provide a stable income stream?
No, Lantheus Holdings doesn't provide an income stream by paying out dividends.
What others are saying about LNTH
One of the reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other traders have to say.
Step 5: Make your LNTH purchase
You have two main order types:
- Market order: A market order is an order to buy or sell a stock at the best available price.
Market orders are mostly sufficient. - Limit order: A limit order is an order to buy or sell a stock at a specific price (or better).
If you want to be sure you're buying or selling at a specific dollar amount limit, place a limit order.
Press the Open button and eToro will execute your order.
If you require additional help with buying stocks on eToro, click the how to video below:
Step 6: Track your investment in LNTH
Now that you own some LNTH shares, you'll want to keep up with your new shares.
Start a watchlist to see the latest developments about your LNTH stock.
LNTH Feed
How to Buy Stock in Lantheus Holdings
To reiterate, here are the 6 steps you need to take to buy Lantheus Holdings stock right now:
- Choose where to buy Lantheus Holdings stock
- Sign up for your brokerage account
- Deposit money your brokerage account
- Research Lantheus Holdings stock
- Make your LNTH purchase
- Track your investment in LNTH
If you need a online brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you would like to get the latest scoop on your new investment in Lantheus Holdings, click below.
Other Content You May Find Useful
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.